Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Study:

n/a

Rationale:

n/a

Purpose:

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Diabetes Mellitus, Non-Insulin-Dependent Drug: Glucovance (metformin HCl/glyburide)
Drug: metformin HCl
Drug: glyburide
Phase 3

Verified by Bristol-Myers Squibb April, 2011

Sponsored by: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb
ClinicalTrials.gov identifier: NCT00035542

Study Type: Interventional

Study Design: Primary Purpose: Treatment

The Cleveland Clinic Children`s Hospital/Dept of Pediatrics
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site